Chemical Compound

cefprozil

CAS Registry Number 92665-29-7

Back to search Request a Quote

Primary Record

cefprozil

In stock: 9,237 g
Purity: 98.3 %
CAS: 92665-29-7

Compound Identifiers & Properties

CAS: 92665-29-7
PubChem CID: 5281006
SMILES: C/C=C/C1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O
Canonical SMILES: C/C=C/C1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1

Names & Synonyms

cefprozil
Cefprozil anhydrous
Cefprozilum
Brisoral
Procef
Cefprozilo
Cronocef
Arzimol
Serozil
Cefzil
cefprozile
trans-Cefprozil
cephprozyl
E-Cefprozil
cis-cefprozil
Cefprozilum [INN-Latin]
Cefprozil (E)-isomer
Cefprozilo [INN-Spanish]
Cefprozil (INN)
Cefprozil hydrate
(E)-cefprozil
Cefzil (TN)
?Cefprozil hydrate
Cefprozil (TN)
92665-29-7
Cefprozil [USAN]
Procef (TN)
Cefprozil Impurity 8
S1SDI2FJIY
Cefprozil [USAN:INN]
AC1NQXVS
UNII-S1SDI2FJIY
BMY 28100
Cefprozil anhydrous, e-isomer
CEFPROZIL [MART.]
D0YX4S
Cefprozil hydrate (Cefzil)
UNII-1M698F4H4E
C18H19N3O5S
BIDD:GT0833
SCHEMBL537035
CEFPROZIL E-FORM [MI]
CHEBI:3506
CHEMBL276568
CEFPROZIL ANHYDROUS, (E)-
Cefprozil for peak identification
HY-B0458A
DTXSID10873545
N,N-BISBENZYLIDENEBENZIDINE
WDLWHQDACQUCJR-ZAMMOSSLSA-N
1M698F4H4E
92676-86-3
HMS3715P22
BBS-1067
ZINC3776970
BMY-28100
BMY-28167
C18-H19-N3-O5-S
EBC-26906
MFCD00911719
AKOS015895989
CCG-221280
CID5281006
DB01150
FC19868
AN-14731
AS-14301
BC208630
DISCONTINUED. Please see C243933.
J363.502C
J397.917B
LS-149959
CS-0013517
FT-0658018
NS00011560
C06888
C16732
D07651
AB01274812-01
AB01274812_02
665C297
EN300-19766374
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6S,7R)-7-((R)-2-Amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-((E)-prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Cefprozil, mix of Z (92%), and E (7%) isomers
I06-1766
Q3231623
BRD-K24871708-002-02-0
BRD-K24871708-002-03-8
BRD-K24871708-002-04-6
CEFPROZIL (E)-ISOMER (50 MG)G0D341872UG/MG(AI)
Cefprozil - mix of Z (92%), and E (7%) isomers
(6R,7R)-7-((R)-2-Amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-((E)-prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
121123-17-9
(6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, (6R,7R)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, (6R-(6alpha,7beta(R*)))-
(6R,7R)-7-((R)-2-Amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-3-((E)-prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
(6R,7R)-7-((R)-2-AMINO-2-(P-HYDROXYPHENYL)ACETAMIDO)-8-OXO-3-PROPENYL-5-THIA-1-AZABICYCLO(4.2.0)OCT-2(E)-ENE-2-CARBOXYLIC ACID
(6R,7R)-7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-[(1E)-prop-1-en-1-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(R)-2-Amino-2-(4-hydroxyphenyl)acetylamino]-8-oxo-3-[(E)-1-propenyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(R)-2-Amino-2-(p-hydroxyphenyl)acetylamino]-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1-propen-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic a cid
(6R,7R)-7-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-[(1E)-prop-1-en-1-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((2R)-AMINO(4-HYDROXYPHENYL)ACETYL)AMINO)-8-OXO-3-(1E)-1-PROPENYL-,(6R,7R)-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-amino(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1-propenyl)-, (6R,7R)-